Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis

Identifieur interne : 005D61 ( Main/Merge ); précédent : 005D60; suivant : 005D62

Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis

Auteurs : Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Si-Ryung Han [Corée du Sud] ; Yong-An Chung [Corée du Sud]

Source :

RBID : ISTEX:C66C79ABD3426B8B5EF65CACF617FA234099243A

English descriptors

Abstract

We describe the case of a 61‐year‐old woman who developed extrapontine myelinolysis (EPM) with parkinsonism. Decreased striatal dopamine transporter binding assessed by [123I]N‐(3‐iodopropen‐2‐yl)‐2β‐carbomethoxy‐3β‐(4‐chlorophenyl) tropane and single photon emission computed tomography ([123I]IPT) SPECT) were observed in the patient, suggesting that osmotic injury causes the demyelination of nigrostriatal dopaminergic neurons and that such injury may be involved in the pathogenesis of EPM with parkinsonism.

Url:
DOI: 10.1002/mds.10331

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:C66C79ABD3426B8B5EF65CACF617FA234099243A

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis</title>
<author>
<name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
</author>
<author>
<name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author>
<name sortKey="Han, Si Yung" sort="Han, Si Yung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
</author>
<author>
<name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C66C79ABD3426B8B5EF65CACF617FA234099243A</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10331</idno>
<idno type="url">https://api.istex.fr/document/C66C79ABD3426B8B5EF65CACF617FA234099243A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003323</idno>
<idno type="wicri:Area/Istex/Curation">003323</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A68</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Kim J:decreased:striatal:dopamine</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12621642</idno>
<idno type="wicri:Area/PubMed/Corpus">003825</idno>
<idno type="wicri:Area/PubMed/Curation">003825</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003824</idno>
<idno type="wicri:Area/Ncbi/Merge">000A26</idno>
<idno type="wicri:Area/Ncbi/Curation">000A26</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A26</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Kim J:decreased:striatal:dopamine</idno>
<idno type="wicri:Area/Main/Merge">005D61</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis</title>
<author>
<name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Han, Si Yung" sort="Han, Si Yung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2003-03">2003-03</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="342">342</biblScope>
<biblScope unit="page" to="345">345</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C66C79ABD3426B8B5EF65CACF617FA234099243A</idno>
<idno type="DOI">10.1002/mds.10331</idno>
<idno type="ArticleID">MDS10331</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Hyponatremia (complications)</term>
<term>Hyponatremia (therapy)</term>
<term>IPT SPECT</term>
<term>Isotonic Solutions (therapeutic use)</term>
<term>Levodopa (therapeutic use)</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins (metabolism)</term>
<term>Middle Aged</term>
<term>Myelinolysis, Central Pontine (etiology)</term>
<term>Myelinolysis, Central Pontine (metabolism)</term>
<term>Myelinolysis, Central Pontine (radionuclide imaging)</term>
<term>Nerve Tissue Proteins</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (etiology)</term>
<term>Parkinsonian Disorders (radionuclide imaging)</term>
<term>Protein Binding</term>
<term>Radiopharmaceuticals (diagnostic use)</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Treatment Outcome</term>
<term>Tropanes (diagnostic use)</term>
<term>extrapontine myelinolysis</term>
<term>parkinsonism</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en">
<term>Radiopharmaceuticals</term>
<term>Tropanes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Transport Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Isotonic Solutions</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Membrane Glycoproteins</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Hyponatremia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Hyponatremia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Protein Binding</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We describe the case of a 61‐year‐old woman who developed extrapontine myelinolysis (EPM) with parkinsonism. Decreased striatal dopamine transporter binding assessed by [123I]N‐(3‐iodopropen‐2‐yl)‐2β‐carbomethoxy‐3β‐(4‐chlorophenyl) tropane and single photon emission computed tomography ([123I]IPT) SPECT) were observed in the patient, suggesting that osmotic injury causes the demyelination of nigrostriatal dopaminergic neurons and that such injury may be involved in the pathogenesis of EPM with parkinsonism.</div>
</front>
</TEI>
<double doi="10.1002/mds.10331">
<ISTEX>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis</title>
<author>
<name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
</author>
<author>
<name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author>
<name sortKey="Han, Si Yung" sort="Han, Si Yung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
</author>
<author>
<name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C66C79ABD3426B8B5EF65CACF617FA234099243A</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10331</idno>
<idno type="url">https://api.istex.fr/document/C66C79ABD3426B8B5EF65CACF617FA234099243A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003323</idno>
<idno type="wicri:Area/Istex/Curation">003323</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A68</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Kim J:decreased:striatal:dopamine</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis</title>
<author>
<name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Han, Si Yung" sort="Han, Si Yung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2003-03">2003-03</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="342">342</biblScope>
<biblScope unit="page" to="345">345</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C66C79ABD3426B8B5EF65CACF617FA234099243A</idno>
<idno type="DOI">10.1002/mds.10331</idno>
<idno type="ArticleID">MDS10331</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>IPT SPECT</term>
<term>extrapontine myelinolysis</term>
<term>parkinsonism</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We describe the case of a 61‐year‐old woman who developed extrapontine myelinolysis (EPM) with parkinsonism. Decreased striatal dopamine transporter binding assessed by [123I]N‐(3‐iodopropen‐2‐yl)‐2β‐carbomethoxy‐3β‐(4‐chlorophenyl) tropane and single photon emission computed tomography ([123I]IPT) SPECT) were observed in the patient, suggesting that osmotic injury causes the demyelination of nigrostriatal dopaminergic neurons and that such injury may be involved in the pathogenesis of EPM with parkinsonism.</div>
</front>
</TEI>
</ISTEX>
<PubMed>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis.</title>
<author>
<name sortKey="Kim, Joong Seok" sort="Kim, Joong Seok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Kwang Soo" sort="Lee, Kwang Soo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author>
<name sortKey="Han, Si Ryung" sort="Han, Si Ryung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
</author>
<author>
<name sortKey="Chung, Yong An" sort="Chung, Yong An" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12621642</idno>
<idno type="pmid">12621642</idno>
<idno type="doi">10.1002/mds.10331</idno>
<idno type="wicri:Area/PubMed/Corpus">003825</idno>
<idno type="wicri:Area/PubMed/Curation">003825</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003824</idno>
<idno type="wicri:Area/Ncbi/Merge">000A26</idno>
<idno type="wicri:Area/Ncbi/Curation">000A26</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A26</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Kim J:decreased:striatal:dopamine</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis.</title>
<author>
<name sortKey="Kim, Joong Seok" sort="Kim, Joong Seok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lee, Kwang Soo" sort="Lee, Kwang Soo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name>
</author>
<author>
<name sortKey="Han, Si Ryung" sort="Han, Si Ryung" uniqKey="Han S" first="Si-Ryung" last="Han">Si-Ryung Han</name>
</author>
<author>
<name sortKey="Chung, Yong An" sort="Chung, Yong An" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Hyponatremia (complications)</term>
<term>Hyponatremia (therapy)</term>
<term>Isotonic Solutions (therapeutic use)</term>
<term>Levodopa (therapeutic use)</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins (metabolism)</term>
<term>Middle Aged</term>
<term>Myelinolysis, Central Pontine (etiology)</term>
<term>Myelinolysis, Central Pontine (metabolism)</term>
<term>Myelinolysis, Central Pontine (radionuclide imaging)</term>
<term>Nerve Tissue Proteins</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (etiology)</term>
<term>Parkinsonian Disorders (radionuclide imaging)</term>
<term>Protein Binding</term>
<term>Radiopharmaceuticals (diagnostic use)</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Treatment Outcome</term>
<term>Tropanes (diagnostic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en">
<term>Radiopharmaceuticals</term>
<term>Tropanes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Transport Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Isotonic Solutions</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Membrane Glycoproteins</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Hyponatremia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en">
<term>Myelinolysis, Central Pontine</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Hyponatremia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Protein Binding</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We describe the case of a 61-year-old woman who developed extrapontine myelinolysis (EPM) with parkinsonism. Decreased striatal dopamine transporter binding assessed by [(123)I]N-(3-iodopropen-2-yl)-2beta-carbomethoxy-3beta-(4-chlorophenyl) tropane and single photon emission computed tomography ([(123)I]IPT) SPECT) were observed in the patient, suggesting that osmotic injury causes the demyelination of nigrostriatal dopaminergic neurons and that such injury may be involved in the pathogenesis of EPM with parkinsonism.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005D61 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005D61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:C66C79ABD3426B8B5EF65CACF617FA234099243A
   |texte=   Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024